About LSL Pharma Group
LSL Pharma Group is a company based in Boucherville (Canada) founded in 2023.. LSL Pharma Group has completed 4 acquisitions, including Dermolabpharma, Du-Var and TargetCo. LSL Pharma Group offers products and services including Pharmaceutical Products, Natural Health Products, and Cosmetics. LSL Pharma Group operates in a competitive market with competitors including Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others.
- Headquarter Boucherville, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lsl Pharma Group Inc
-
Annual Revenue
$12.34 M (USD)76.98as on Dec 31, 2024
-
Net Profit
$2.31 M (USD)0as on Dec 31, 2024
-
EBITDA
$1.33 M (USD)0as on Dec 31, 2024
-
Latest Funding Round
$1.65 M (USD), Post-IPO
Sep 02, 2025
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Dermolabpharma
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of LSL Pharma Group
LSL Pharma Group is a publicly listed company on the TSXV with ticker symbol LSL in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of LSL Pharma Group
LSL Pharma Group offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Natural Health Products, and Cosmetics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufacture sterile pharmaceuticals for health applications
Develop and distribute natural supplements for wellness
Formulate and produce cosmetic and pharmaceutical health items
Funding Insights of LSL Pharma Group
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $1.7M
-
First Round
First Round
(21 Sep 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Post-IPO - LSL Pharma Group | Valuation |
investors |
|
| Dec, 2024 | Amount | Post-IPO - LSL Pharma Group | Valuation |
investors |
|
| Jul, 2024 | Amount | Post-IPO - LSL Pharma Group | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by LSL Pharma Group
LSL Pharma Group has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Dermolabpharma, Du-Var and TargetCo. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Natural supplements and healthcare products are provided for wellness.
|
1994 | ||||
|
Natural cosmetic, pharmaceutical, and health products are manufactured.
|
1985 | ||||
|
Skincare and cosmetic manufacturing services in Canada.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - LSL Pharma Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lsl Pharma Group Comparisons
Competitors of LSL Pharma Group
LSL Pharma Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
Biotech company developing personalized medicines for cardiovascular diseases
|
|
| domain | founded_year | HQ Location |
APIs and finished dosage forms are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lsl Pharma Group
Frequently Asked Questions about LSL Pharma Group
When was LSL Pharma Group founded?
LSL Pharma Group was founded in 2023.
Where is LSL Pharma Group located?
LSL Pharma Group is headquartered in Boucherville, Canada. It is registered at Boucherville, Quebec, Canada.
Who is the current CEO of LSL Pharma Group?
Francois Roberge is the current CEO of LSL Pharma Group.
What is the annual revenue of LSL Pharma Group?
Annual revenue of LSL Pharma Group is $12.34M as on Dec 31, 2024.
What does LSL Pharma Group do?
Groupe LSL Pharma was established in 2023 in Boucherville, Canada, as an integrated pharmaceutical entity. Focus is placed on life science innovations to address needs within the Canadian population. Operations encompass product development and distribution in the pharmaceutical sector. Recent developments include secured orders projected to generate over 2.6 million in annual revenue. Leadership is provided by CEO Francois Roberge.
Who are the top competitors of LSL Pharma Group?
LSL Pharma Group's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
What products or services does LSL Pharma Group offer?
LSL Pharma Group offers Pharmaceutical Products, Natural Health Products, and Cosmetics.
Is LSL Pharma Group publicly traded?
Yes, LSL Pharma Group is publicly traded on TSXV under the ticker symbol LSL.
How many acquisitions has LSL Pharma Group made?
LSL Pharma Group has made 4 acquisitions, including Dermolabpharma, Du-Var, and TargetCo.
What is LSL Pharma Group's ticker symbol?
The ticker symbol of LSL Pharma Group is LSL on TSXV.